Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, ACC

AB Electrolux publishes 2023 Annual Report


STOCKHOLM, Feb. 22, 2024 /PRNewswire/ -- AB Electrolux Annual Report for 2023 has been published on the Group's website as of today.

The Annual Report in Swedish as well as an English translation are available on www.electroluxgroup.com in pdf-format. The Swedish Annual Report is also available on the Group's website in European Single Electronic Format (ESEF).

This disclosure contains information that AB Electrolux is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 22-02-2024 08:00 CET.

For more information:
Maria Åkerhielm, Investor Relations, +46 70 796 3856
Electrolux Group Press Hotline, +46 8 657 65 07

The following files are available for download:

https://mb.cision.com/Main/1853/3933351/2620376.pdf

ELECTROLUX ASR23 240221

 

SOURCE Electrolux Group


These press releases may also interest you

at 22:17
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of information and communication technology solutions, today announced that it was honored with 2023 Climate...

at 22:04
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...

at 21:57
Hikvision has released its full-year 2023 financial results, reporting a total revenue of RMB 89.34 billion, up 7.42% year-over-year. Net profit attributable to shareholders of the company was RMB 14.11 billion, achieving a year-over-year (YoY)...

at 21:05
DTEN, a leading provider of video conferencing solutions, is proud to announce that their flagship All-in-One solution, the DTEN D7X series, is now available to purchase in South Korea after it has successfully passed the rigorous certification...

at 20:15
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...

at 18:47
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...



News published on and distributed by: